Stepan(SCL)
Search documents
Stepan(SCL) - 2024 Q1 - Earnings Call Transcript
2024-04-30 17:10
Vincent Anderson - Stifel Mike Harrison - Seaport Research Partners Dave Storms - Stonegate With that, I would like to turn the call over to Mr. Scott Behrens, our President and Chief Executive Officer. We generated positive free cash flow of $11.4 million as capital expenditures returned to historical levels, and these results give us confidence that we will close 2024 with positive free cash flow. The company is on track to deliver our $50 million cost reduction goal for 2024 through disciplined efforts i ...
Stepan(SCL) - 2024 Q1 - Quarterly Results
2024-04-30 11:00
Exhibit 99.1 Stepan Reports First Quarter 2024 Results Northbrook, Illinois, April 30, 2024 -- Stepan Company (NYSE: SCL) today reported: First Quarter 2024 Highlights • Reported net income was $13.9 million. Adjusted net income(1) was $14.7 million, down 11% year-over-year, largely due to a higher effective tax rate in 2024. • EBITDA(2) was $50.2 million. Adjusted EBITDA(2) was $51.2 million, up 5% year-over-year. • Global sales volume was up 1% year-over-year. Global sales volume, excluding declines in ou ...
Stepan(SCL) - 2023 Q4 - Annual Report
2024-02-29 16:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-4462 STEPAN COMPANY ANNUAL REPORT ON FORM 10-K December 31, 2023 | Item 1. | Business | 3 | | --- | --- | --- | | | Information About o ...
Stepan(SCL) - 2023 Q4 - Earnings Call Transcript
2024-02-20 18:45
Company Participants Conference Call Participants Mike Harrison - Seaport Research Partners Vincent Anderson - Stifel David Silver - CL King and Associates Dave Storms - Stonegate Operator Luis Rojo In addition, this conference call will include discussions of adjusted net income, adjusted EBITDA and free cash flow, which are noon-GAAP measures. We provide reconciliations to the comparable GAAP measures in the earnings presentation and press release, which we have made available at www.stepan.com under the ...
Stepan(SCL) - 2023 Q3 - Quarterly Report
2023-11-02 16:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-4462 STEPAN COMPANY (Exact name of registrant as specified in its charter) | Delaware | | --- | (State or other jurisdiction of i ...
Stepan(SCL) - 2023 Q3 - Earnings Call Transcript
2023-10-18 21:32
Financial Data and Key Metrics - Adjusted net income for Q3 2023 was $14.7 million, a significant decline from $46.3 million in the prior year [23][29] - Adjusted EBITDA for Q3 2023 was $48 million, down from $85 million in the prior year, primarily due to a 9% decline in sales volume [23][26] - Surfactant operating income was $15.4 million, down from $39 million in the prior year, driven by a 7% decline in global sales volume and lower unit margins in Latin America [26] - Polymer operating income was $21.8 million, down from $31.9 million in the prior year, with a 12% decline in global sales volume, particularly in Rigid Polyols [27] - Specialty Product operating income was $2.4 million, down from $9.7 million in the prior year, due to lower sales volume and unit margins within the MCT product line [30] Business Line Data and Key Metrics - Surfactant volumes grew by 2% sequentially, driven by double-digit growth in personal care and mid-single-digit growth in laundry and cleaning [41] - Polymer volumes increased 6% sequentially, with high single-digit growth in global Rigid Polyols, partially offset by a 25% decline in commodity PA business [37] - Specialty Product volumes were impacted by order timing differences, leading to a sequential decline in operating income [37] Market Data and Key Metrics - Latin America saw high-single-digit volume growth in Surfactants, but margins were pressured by competitive imports [24][26] - China's Polymer business showed strong double-digit growth in Q3, driven by market diversification efforts [61] - Agricultural end-market demand remained low due to continued destocking, impacting Surfactant earnings [33][64] Company Strategy and Industry Competition - The company is focusing on cost reduction, targeting $50 million in pre-tax savings in 2024 through workforce productivity and operational improvements [52] - Investments in low 1,4 dioxane production capacity and the Pasadena alkoxylation facility are expected to drive future growth, with the latter set to be operational by mid-2024 [25][55] - The company is diversifying its Polymer business in China, moving beyond traditional construction markets [7] Management Commentary on Operating Environment and Future Outlook - Management expects continued destocking in the agricultural market through Q4 2023, with recovery anticipated in 2024 [43][76] - Raw material costs are stabilizing, and the company expects improved margins in Q4 2023, except for the MCT business, which is still impacted by high-cost inventory [99] - The company anticipates a recovery in Rigid Polyols demand and growth in Surfactant volumes driven by new contracted business in 2024 [44] Other Important Information - The company paid $8.2 million in dividends in Q3 2023 and has $125 million remaining under its share repurchase program [28] - Inventory levels were reduced by $55 million in Q3 2023, with plans to further reduce inventories by $25 million in Q4 [25][48] - The company declared a quarterly cash dividend of $0.375 per share, marking a 3% increase and the 56th consecutive year of dividend payments [31] Q&A Session Summary Question: Customer acquisition trends across Tier 1, Tier 2, and Tier 3 customers - The company continues to see robust growth in Tier 2 and Tier 3 customer acquisition, though market demand and destocking in 2023 have offset some of this momentum [2] Question: Polyols segment margins and China's construction market - Polymer unit margins have stabilized, with sequential volume growth observed from Q1 to Q3 2023 [6] - The company has diversified its Polymer business in China, leading to strong growth in non-traditional markets [7] Question: Opportunities in spray foam and PA production - The company is actively pursuing new customer approvals in the spray foam market, despite overall market conditions [9] - There are no plans to produce PA at the INVISTA assets, as Millsdale remains the sole PA production site [9][10] Question: $50 million cost savings plan for 2024 - The savings will come from operational efficiencies, including logistics, procurement, and inventory management, with additional workforce productivity activities planned for Q4 2023 [13] Question: Impact of Pasadena plant startup costs - The Pasadena plant is expected to incur $7 million to $10 million in additional costs in 2024, with benefits from savings and productivity improvements expected in the second half of the year [62][63] Question: Agricultural destocking and its impact on Surfactants - Agricultural destocking has lagged other markets, with a double-digit decline in volumes impacting Surfactant earnings in Q3 2023 [64][79] Question: Long-term outlook for the Surfactants industry - The Surfactants industry has experienced unprecedented volatility due to supply chain constraints and inventory reconciliation, but the company remains confident in its long-term growth prospects [68][93] Question: Gross margin trends and raw material costs - The company expects gross margins to stabilize in Q4 2023, with raw material costs now aligned with market prices, except for the MCT business [99] Question: Cash flow and CapEx outlook for 2024 - The company expects CapEx to return to historical levels in 2024, with depreciation estimated between $130 million to $132 million [82]
Stepan(SCL) - 2023 Q2 - Earnings Call Presentation
2023-08-10 08:24
Stepan S Cautionary Statement Earnings Call Presentation Second Quarter 2023 July 26, 2023 Certain information in this presentation consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amoun ...
Stepan(SCL) - 2023 Q2 - Quarterly Report
2023-08-03 14:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-4462 STEPAN COMPANY (Exact name of registrant as specified in its charter) Delaware 36-1823834 (State or other jurisdiction of incorpo ...
Stepan(SCL) - 2023 Q2 - Earnings Call Transcript
2023-07-26 18:04
Conference Call Participants Good day, and thank you for standing by, and welcome to the Q2 2023 Stepan Company Earnings Conference Call. [Operator Instructions]. Good morning, and thank you for joining Stepan Company's Second Quarter 2023 Financial Review. Before we begin, please note that information in this conference call contain forward-looking statements. which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including, bu ...
Stepan(SCL) - 2023 Q1 - Quarterly Report
2023-05-04 16:49
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-4462 STEPAN COMPANY (Exact name of registrant as specified in its charter) Delaware 36-1823834 (State or other jurisdiction of incorp ...